Capital Partnerships
Sector-led deal origination across life sciences.
NorthPoint:Bio provides independent deal origination capabilities to private equity firms, growth equity investors, strategic investors and specialist capital providers operating across the life sciences sector.
We support investment teams in identifying differentiated opportunities, expanding proprietary deal flow and developing relationships with prospective investment targets across pharmaceuticals, biotechnology, MedTech and diagnostics.
Our approach combines sector expertise, thematic sourcing and senior-level commercial engagement to identify and develop opportunities aligned with specific investment mandates across Europe and the United States.
Targeted deal sourcing, engagement and opportunity development.
IDENTIFY
Sector mapping and investment universe development
Target identification against defined investment criteria
Origination of proprietary and off-market opportunities
Preliminary commercial screening and strategic fit assessment
ENGAGE
Direct engagement with founders, CEOs and senior management
Development of relationships with prospective investment targets
Assessment of strategic alignment and transaction readiness
Expansion of investor coverage across European and US markets
DEVELOP
Qualification and prioritisation of investment opportunities
Development of actionable deal pipelines
Progression of management relationships and investment dialogue
Ongoing origination support aligned with investment mandates